We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$365M
AUM Growth
+$48.9M
Cap. Flow
+$48.2M
Cap. Flow %
13.21%
Top 10 Hldgs %
51.36%
Holding
54
New
2
Increased
24
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
XNCR icon
Xencor
XNCR
+$14M
2
NEO icon
NeoGenomics
NEO
+$13.3M
3
CSII
Cardiovascular Systems, Inc.
CSII
+$11.2M
4
NVRO
NEVRO CORP.
NVRO
+$7.68M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$6.76M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$8.16M
2
NKTR icon
Nektar Therapeutics
NKTR
+$5.97M
3
IMMU
Immunomedics Inc
IMMU
+$4.33M
4
MGNX icon
MacroGenics
MGNX
+$1.46M
5
STRM
Streamline Health Solutions
STRM
+$590K

Sector Composition

Rank Sector Weight
1 Healthcare 84.02%
2 Communication Services 4.08%
3 Energy 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEO icon
1
NeoGenomics
NEO
$1.96B
$34.1M 9.35%
3,847,602
+1,439,672
+60% +$13.3M
NKTR icon
2
Nektar Therapeutics
NKTR
$2.39B
$21M 5.76%
23,449
-10,097
-30% -$5.97M
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
$20.1M 5.5%
1,566,804
+97,343
+7% +$1.11M
ATRC icon
4
AtriCure
ATRC
$1.92B
$19.6M 5.38%
1,075,447
+41,711
+4% +$826K
ENTL
5
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$16.4M 4.49%
670,904
+38,167
+6% +$734K
OMCL icon
6
Omnicell
OMCL
$1.61B
$15.4M 4.22%
317,331
+19,112
+6% +$964K
LGND icon
7
Ligand Pharmaceuticals
LGND
$5.76B
$15.3M 4.2%
179,490
+77,946
+77% +$6.76M
HBIO icon
8
Harvard Bioscience
HBIO
$27.5M
$15.3M 4.2%
463,865
+52,237
+13% +$1.76M
IMMU
9
DELISTED
Immunomedics Inc
IMMU
$15.3M 4.19%
944,404
-367,110
-28% -$4.33M
MODN
10
DELISTED
MODEL N, INC.
MODN
$14.9M 4.08%
944,125
+92,417
+11% +$1.39M
XNCR icon
11
Xencor
XNCR
$1.5B
$14.1M 3.88%
+644,764
New +$14M
SHPG
12
DELISTED
Shire pic
SHPG
$12.3M 3.39%
79,607
+5,137
+7% +$761K
NVRO
13
DELISTED
NEVRO CORP.
NVRO
$10.8M 2.95%
155,904
+95,999
+160% +$7.68M
CSII
14
DELISTED
Cardiovascular Systems, Inc.
CSII
$10.5M 2.88%
+444,004
New +$11.2M
HALO icon
15
Halozyme
HALO
$9.79B
$9.47M 2.6%
467,646
+21,800
+5% +$401K
OXFD
16
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$8.34M 2.29%
596,778
+34,401
+6% +$504K
DVAX
17
DELISTED
Dynavax Technologies
DVAX
$7.77M 2.13%
415,573
+141,643
+52% +$2.84M
HRTX icon
18
Heron Therapeutics
HRTX
$93.9M
$7.49M 2.05%
413,721
+20,216
+5% +$330K
GMED icon
19
Globus Medical
GMED
$10.7B
$7.25M 1.99%
176,457
-2,559
-1% -$89.6K
BLUE
20
DELISTED
bluebird bio
BLUE
$6.74M 1.85%
2,921
+135
+5% +$274K
CDXS icon
21
Codexis
CDXS
$151M
$6.71M 1.84%
804,224
+459,234
+133% +$3.18M
XENT
22
DELISTED
Intersect ENT, Inc
XENT
$5.8M 1.59%
178,896
+8,699
+5% +$261K
TLGT
23
DELISTED
Teligent, Inc
TLGT
$5.46M 1.5%
150,313
+1,979
+1% +$94.7K
QDEL icon
24
QuidelOrtho
QDEL
$1.14B
$5.2M 1.43%
119,901
-2,608
-2% -$107K
VCYT icon
25
Veracyte
VCYT
$3.7B
$5.17M 1.42%
791,337
-50,622
-6% -$376K
1
2 3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, First Light Asset Management held 54 positions worth $365M, up 15% from $316M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

First Light Asset Management deployed $48.2M of net new capital in Q4 2017, opening 2 new positions and adding to 24 existing holdings. Its largest new stake was Xencor: 644,764 shares worth $14.1M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 82% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Nektar Therapeutics, an estimated $5.97M trimmed.

  • First Light Asset Management's largest Q4 2017 buy was Xencor: 644,764 shares worth $14.1M.
  • First Light Asset Management added most to NeoGenomics in Q4 2017, an estimated $13.3M increase.
  • First Light Asset Management's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $5.97M.
  • First Light Asset Management fully exited Medicines Co in Q4 2017, selling an estimated $8.16M.
  • First Light Asset Management's ten largest holdings make up 51% of its $365M portfolio in Q4 2017.
  • First Light Asset Management opened 2 new positions and closed 2 in Q4 2017.
  • First Light Asset Management's portfolio value rose 15% quarter-over-quarter to $365M.

Based on First Light Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.